Jacobs Engineering Group Inc. has recently been awarded a contract to expand the Novartis Pharma S.A.S. Biotechnology Center in Huningue, France. Under the terms of the agreement, Jacobs is providing engineering, procurement and construction management (EPCM) services to increase the siteâs production capacity by 70 percent and create a second line of purification that allows for multiple drugs to be manufactured simultaneously. The expansion project adds cell culture bioreactors to the site. Jacobsâ services are being led from its operations in Milan, Italy.
Jacobs Senior Vice President Life Sciences Robert Norfleet stated, âWe look forward to partnering with Novartis on the expansion of its Huningue site. Weâre proud to have this opportunity to draw on our extensive global EPCM expertise for a project that can help Novartis improve the lives of people who depend on its treatments.â? The USD 100M expansion project is scheduled to be completed in four years.
